Alpha Cognition Current Ratio 2020-2024 | ACOG
Alpha Cognition current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Alpha Cognition Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-06-30 |
$0.00B |
$0.00B |
0.96 |
| 2024-03-31 |
$0.00B |
$0.00B |
1.32 |
| 2023-12-31 |
$0.00B |
$0.00B |
0.73 |
| 2023-09-30 |
$0.00B |
$0.00B |
0.40 |
| 2023-06-30 |
$0.00B |
$0.00B |
1.32 |
| 2023-03-31 |
$0.00B |
$0.00B |
2.04 |
| 2022-12-31 |
$0.00B |
$0.00B |
0.58 |
| 2022-09-30 |
$0.00B |
$0.00B |
1.66 |
| 2022-06-30 |
$0.01B |
$0.00B |
3.08 |
| 2022-03-31 |
$0.01B |
$0.00B |
5.29 |
| 2021-12-31 |
$0.01B |
$0.00B |
6.75 |
| 2021-09-30 |
$0.01B |
$0.00B |
5.73 |
| 2021-06-30 |
$0.01B |
$0.00B |
5.99 |
| 2021-03-31 |
$0.01B |
$0.00B |
11.57 |
| 2020-12-31 |
$0.01B |
$0.00B |
2.15 |
| 2020-09-30 |
$0.00B |
|
0.00 |
| 2020-06-30 |
$0.00B |
|
0.00 |
| 2020-03-31 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.01B |
$0.00B |
17.41 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
